Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo

Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo

US Patent 10653123 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of assessing the efficacy of a test agent for modulating programmed death2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
Modulating biomarkers such as SPP to increase tumor immunity and improve the eff2024
Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and2024
Antibody molecules to PD-1 and uses thereof2023
Modulating biomarkers to increase tumor immunity and improve the efficacy of can2023
Methods of treating cancer using LSD1 inhibitors in combination with immunothera2023
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, metho2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2022
Methods and compositions for the treatment of persistent infections and cancer b2022
Agents that modulate immune cell activation and methods of use thereof2022
Regulatory T cell PD-1 modulation for regulating T cell effector immune response2021